|
|
establishment of melanosome localization
|
GO:0032401 |
11 |
1.000
|
|
|
|
pigment cell differentiation
|
GO:0050931 |
27 |
1.000
|
|
|
|
pigmentation
|
GO:0043473 |
71 |
1.000
|
|
|
|
melanocyte differentiation
|
GO:0030318 |
25 |
1.000
|
|
|
|
pigment granule localization
|
GO:0051875 |
13 |
1.000
|
|
|
|
melanosome localization
|
GO:0032400 |
12 |
1.000
|
|
|
|
developmental pigmentation
|
GO:0048066 |
40 |
1.000
|
|
|
|
pigment accumulation
|
GO:0043476 |
1 |
1.000
|
|
|
|
melanosome transport
|
GO:0032402 |
11 |
1.000
|
|
|
|
pigment metabolic process
|
GO:0042440 |
32 |
0.999
|
|
|
|
secondary metabolic process
|
GO:0019748 |
18 |
0.998
|
|
|
|
pigment biosynthetic process
|
GO:0046148 |
26 |
0.998
|
|
|
|
cellular pigmentation
|
GO:0033059 |
20 |
0.997
|
|
|
|
pigment granule transport
|
GO:0051904 |
12 |
0.997
|
|
|
|
vesicle localization
|
GO:0051648 |
86 |
0.995
|
|
|
|
melanin metabolic process
|
GO:0006582 |
12 |
0.995
|
|
|
|
neuroepithelial cell differentiation
|
GO:0060563 |
37 |
0.988
|
|
|
|
regulation of pigment cell differentiation
|
GO:0050932 |
7 |
0.979
|
|
|
|
melanin biosynthetic process
|
GO:0042438 |
10 |
0.975
|
|
|
|
secondary metabolite biosynthetic process
|
GO:0044550 |
11 |
0.974
|
|
|
|
establishment of pigment granule localization
|
GO:0051905 |
12 |
0.972
|
|
|
|
pigment granule organization
|
GO:0048753 |
9 |
0.965
|
|
|
|
vesicle organization
|
GO:0016050 |
60 |
0.964
|
|
|
|
organelle localization
|
GO:0051640 |
179 |
0.959
|
|
|
|
columnar cuboidal epithelial cell differentiation
|
GO:0002065 |
82 |
0.954
|
|
|
|
melanosome organization
|
GO:0032438 |
8 |
0.951
|
|
|
|
phenol containing compound biosynthetic process
|
GO:0046189 |
21 |
0.951
|
|
|
|
lysosome organization
|
GO:0007040 |
21 |
0.942
|
|
|
|
establishment of vesicle localization
|
GO:0051650 |
81 |
0.941
|
|
|
|
natural killer cell degranulation
|
GO:0043320 |
3 |
0.907
|
|
|
|
establishment of organelle localization
|
GO:0051656 |
122 |
0.888
|
|
|
|
negative regulation of secondary metabolite biosynthetic process
|
GO:1900377 |
2 |
0.867
|
|
|
|
microtubule based movement
|
GO:0007018 |
84 |
0.860
|
|
|
|
synaptic transmission
|
GO:0007268 |
329 |
0.827
|
|
|
|
organic hydroxy compound metabolic process
|
GO:1901615 |
203 |
0.817
|
|
|
|
regulation of leukocyte differentiation
|
GO:1902105 |
159 |
0.779
|
|
|
|
regulation of body fluid levels
|
GO:0050878 |
162 |
0.777
|
|
|
|
blood coagulation
|
GO:0007596 |
76 |
0.761
|
|
|
|
microtubule based transport
|
GO:0010970 |
50 |
0.729
|
|
|
|
lytic vacuole organization
|
GO:0080171 |
21 |
0.708
|
|
|
|
hemostasis
|
GO:0007599 |
78 |
0.657
|
|
|
|
secretory granule localization
|
GO:0032252 |
3 |
0.631
|
|
|
|
response to organonitrogen compound
|
GO:0010243 |
246 |
0.625
|
|
|
|
regulation of developmental pigmentation
|
GO:0048070 |
14 |
0.617
|
|
|
|
cellular nitrogen compound catabolic process
|
GO:0044270 |
280 |
0.608
|
|
|
|
coagulation
|
GO:0050817 |
78 |
0.592
|
|
|
|
cellular amino acid metabolic process
|
GO:0006520 |
103 |
0.559
|
|
|
|
glycosyl compound catabolic process
|
GO:1901658 |
206 |
0.553
|
|
|
|
regulation of reactive oxygen species biosynthetic process
|
GO:1903426 |
2 |
0.550
|
|
|
|
regulation of inositol 1 4 5 trisphosphate sensitive calcium release channel activity
|
GO:0031585 |
2 |
0.539
|
|
|
|
nucleoside triphosphate metabolic process
|
GO:0009141 |
230 |
0.538
|
|
|
|
cytoplasmic transport
|
GO:0016482 |
234 |
0.534
|
Human |
|
|
ribonucleotide metabolic process
|
GO:0009259 |
291 |
0.530
|
|
|
|
aromatic compound catabolic process
|
GO:0019439 |
286 |
0.525
|
|
|
|
positive regulation of developmental pigmentation
|
GO:0048087 |
6 |
0.523
|
|
|
|
leukocyte differentiation
|
GO:0002521 |
342 |
0.515
|
|
|
|
ribonucleoside triphosphate catabolic process
|
GO:0009203 |
199 |
0.514
|
|
|
|
natural killer cell activation involved in immune response
|
GO:0002323 |
10 |
0.509
|
|
|
|
purine nucleotide metabolic process
|
GO:0006163 |
302 |
0.501
|
|
|
|
cellular lipid metabolic process
|
GO:0044255 |
323 |
0.498
|
|
|
|
organophosphate catabolic process
|
GO:0046434 |
232 |
0.497
|
|
|
|
spermatogenesis
|
GO:0007283 |
284 |
0.493
|
|
|
|
dna metabolic process
|
GO:0006259 |
303 |
0.470
|
|
|
|
organic hydroxy compound biosynthetic process
|
GO:1901617 |
77 |
0.468
|
|
|
|
anterograde axon cargo transport
|
GO:0008089 |
20 |
0.467
|
|
|
|
organonitrogen compound catabolic process
|
GO:1901565 |
264 |
0.466
|
|
|
|
membrane organization
|
GO:0061024 |
245 |
0.466
|
|
|
|
maintenance of location
|
GO:0051235 |
89 |
0.464
|
|
|
|
activation of cysteine type endopeptidase activity involved in apoptotic signaling pathway
|
GO:0097296 |
2 |
0.463
|
|
|
|
sphingolipid metabolic process
|
GO:0006665 |
45 |
0.462
|
|
|
|
positive regulation of pigment cell differentiation
|
GO:0050942 |
5 |
0.448
|
|
|
|
protein targeting
|
GO:0006605 |
143 |
0.447
|
|
|
|
negative regulation of melanin biosynthetic process
|
GO:0048022 |
2 |
0.444
|
|
|
|
synaptic vesicle localization
|
GO:0097479 |
59 |
0.444
|
|
|
|
inorganic ion transmembrane transport
|
GO:0098660 |
234 |
0.443
|
|
|
|
fatty acid metabolic process
|
GO:0006631 |
121 |
0.442
|
|
|
|
purine nucleoside catabolic process
|
GO:0006152 |
205 |
0.440
|
|
|
|
long term synaptic potentiation
|
GO:0060291 |
25 |
0.439
|
|
|
|
transmembrane transport
|
GO:0055085 |
412 |
0.438
|
|
|
|
heterocycle catabolic process
|
GO:0046700 |
280 |
0.437
|
|
|
|
regulation of cell activation
|
GO:0050865 |
289 |
0.436
|
|
|
|
regulation of cellular catabolic process
|
GO:0031329 |
242 |
0.435
|
|
|
|
purine ribonucleoside triphosphate catabolic process
|
GO:0009207 |
199 |
0.426
|
|
|
|
monocarboxylic acid metabolic process
|
GO:0032787 |
191 |
0.426
|
|
|
|
positive regulation of reactive oxygen species biosynthetic process
|
GO:1903428 |
2 |
0.425
|
|
|
|
cation transport
|
GO:0006812 |
399 |
0.423
|
|
|
|
organic cyclic compound catabolic process
|
GO:1901361 |
295 |
0.418
|
|
|
|
glycosyl compound metabolic process
|
GO:1901657 |
246 |
0.416
|
|
|
|
nucleotide metabolic process
|
GO:0009117 |
332 |
0.415
|
|
|
|
lipid localization
|
GO:0010876 |
126 |
0.414
|
|
|
|
cytoskeleton dependent intracellular transport
|
GO:0030705 |
50 |
0.414
|
|
|
|
positive regulation of cellular catabolic process
|
GO:0031331 |
148 |
0.411
|
|
|
|
regulation of hydrolase activity
|
GO:0051336 |
246 |
0.407
|
|
|
|
regulation of membrane potential
|
GO:0042391 |
192 |
0.402
|
|
|
|
nucleoside metabolic process
|
GO:0009116 |
246 |
0.398
|
|
|
|
ion transmembrane transport
|
GO:0034220 |
361 |
0.395
|
|
|
|
purine ribonucleotide metabolic process
|
GO:0009150 |
290 |
0.388
|
|
|
|
alpha beta t cell differentiation
|
GO:0046632 |
69 |
0.387
|
|
|
|
regulation of cellular amine metabolic process
|
GO:0033238 |
20 |
0.386
|
|
|
|
reactive oxygen species biosynthetic process
|
GO:1903409 |
8 |
0.385
|
|
|
|
positive regulation of lymphocyte activation
|
GO:0051251 |
140 |
0.383
|
|
|
|
mitochondrial outer membrane permeabilization involved in programmed cell death
|
GO:1902686 |
11 |
0.382
|
|
|
|
carbohydrate derivative catabolic process
|
GO:1901136 |
231 |
0.380
|
|
|
|
positive regulation of cellular amino acid metabolic process
|
GO:0045764 |
3 |
0.380
|
|
|
|
release of cytochrome c from mitochondria
|
GO:0001836 |
23 |
0.378
|
|
|
|
ribonucleoside triphosphate metabolic process
|
GO:0009199 |
220 |
0.377
|
|
|
|
nucleoside catabolic process
|
GO:0009164 |
206 |
0.376
|
|
|
|
lymphocyte differentiation
|
GO:0030098 |
242 |
0.368
|
|
|
|
amine metabolic process
|
GO:0009308 |
45 |
0.365
|
|
|
|
reactive oxygen species metabolic process
|
GO:0072593 |
84 |
0.362
|
|
|
|
guanosine containing compound catabolic process
|
GO:1901069 |
144 |
0.360
|
|
|
|
regulation of t cell activation
|
GO:0050863 |
170 |
0.357
|
|
|
|
ribonucleotide catabolic process
|
GO:0009261 |
208 |
0.351
|
|
|
|
ribonucleoside catabolic process
|
GO:0042454 |
206 |
0.350
|
|
|
|
purine ribonucleoside triphosphate metabolic process
|
GO:0009205 |
220 |
0.349
|
|
|
|
purine ribonucleoside metabolic process
|
GO:0046128 |
241 |
0.349
|
|
|
|
purine containing compound metabolic process
|
GO:0072521 |
311 |
0.342
|
|
|
|
cellular ion homeostasis
|
GO:0006873 |
165 |
0.340
|
|
|
|
positive regulation of hydrolase activity
|
GO:0051345 |
148 |
0.339
|
|
|
|
regulation of reactive oxygen species metabolic process
|
GO:2000377 |
40 |
0.336
|
|
|
|
purine containing compound catabolic process
|
GO:0072523 |
213 |
0.331
|
|
|
|
glial cell apoptotic process
|
GO:0034349 |
3 |
0.330
|
|
|
|
leukocyte homeostasis
|
GO:0001776 |
79 |
0.321
|
|
|
|
nucleotide catabolic process
|
GO:0009166 |
217 |
0.319
|
|
|
|
regulation of ion transport
|
GO:0043269 |
215 |
0.318
|
|
|
|
positive regulation of mitochondrial membrane permeability involved in apoptotic process
|
GO:1902110 |
11 |
0.317
|
|
|
|
purine nucleotide catabolic process
|
GO:0006195 |
211 |
0.316
|
|
|
|
inorganic cation transmembrane transport
|
GO:0098662 |
207 |
0.316
|
|
|
|
secretion of lysosomal enzymes
|
GO:0033299 |
6 |
0.311
|
|
|
|
learning
|
GO:0007612 |
98 |
0.311
|
|
|
|
positive regulation of alpha beta t cell differentiation
|
GO:0046638 |
28 |
0.311
|
|
|
|
purine ribonucleotide catabolic process
|
GO:0009154 |
208 |
0.308
|
|
|
|
anterograde synaptic vesicle transport
|
GO:0048490 |
15 |
0.301
|
|
|
|
positive regulation of nervous system development
|
GO:0051962 |
221 |
0.296
|
|
|
|
neuronal action potential
|
GO:0019228 |
54 |
0.293
|
|
|
|
phenol containing compound metabolic process
|
GO:0018958 |
60 |
0.289
|
|
|
|
cellular response to peptide
|
GO:1901653 |
92 |
0.287
|
|
|
|
cellular amine metabolic process
|
GO:0044106 |
44 |
0.286
|
|
|
|
calcium ion transmembrane transport
|
GO:0070588 |
85 |
0.286
|
|
|
|
alpha amino acid metabolic process
|
GO:1901605 |
59 |
0.278
|
|
|
|
signal transduction in absence of ligand
|
GO:0038034 |
55 |
0.278
|
|
|
|
positive regulation of phagocytosis
|
GO:0050766 |
26 |
0.275
|
|
|
|
modification by symbiont of host morphology or physiology
|
GO:0044003 |
4 |
0.275
|
|
|
|
regulation of lymphocyte activation
|
GO:0051249 |
240 |
0.273
|
|
|
|
purine nucleoside triphosphate metabolic process
|
GO:0009144 |
226 |
0.271
|
|
|
|
peptidyl amino acid modification
|
GO:0018193 |
336 |
0.269
|
|
|
|
response to peptide hormone
|
GO:0043434 |
127 |
0.268
|
|
|
|
gtp metabolic process
|
GO:0046039 |
144 |
0.267
|
|
|
|
positive regulation of cysteine type endopeptidase activity involved in apoptotic signaling pathway
|
GO:2001269 |
3 |
0.266
|
|
|
|
synaptic vesicle transport
|
GO:0048489 |
57 |
0.264
|
|
|
|
apoptotic mitochondrial changes
|
GO:0008637 |
48 |
0.262
|
|
|
|
rho protein signal transduction
|
GO:0007266 |
32 |
0.259
|
|
|
|
regulation of endocytosis
|
GO:0030100 |
69 |
0.259
|
|
|
|
myeloid cell differentiation
|
GO:0030099 |
233 |
0.259
|
|
|
|
nucleoside phosphate metabolic process
|
GO:0006753 |
338 |
0.258
|
|
|
|
response to peptide
|
GO:1901652 |
136 |
0.255
|
|
|
|
cellular macromolecule catabolic process
|
GO:0044265 |
206 |
0.252
|
|
|
|
cognition
|
GO:0050890 |
149 |
0.252
|
|
|
|
positive regulation of cell activation
|
GO:0050867 |
158 |
0.252
|
|
|
|
regulation of alpha beta t cell differentiation
|
GO:0046637 |
35 |
0.251
|
|
|
|
cellular homeostasis
|
GO:0019725 |
240 |
0.249
|
|
|
|
regulation of vesicle mediated transport
|
GO:0060627 |
139 |
0.249
|
|
|
|
gland development
|
GO:0048732 |
330 |
0.248
|
|
|
|
positive regulation of reactive oxygen species metabolic process
|
GO:2000379 |
11 |
0.248
|
|
|
|
male gamete generation
|
GO:0048232 |
285 |
0.247
|
|
|
|
divalent metal ion transport
|
GO:0070838 |
172 |
0.244
|
|
|
|
cell fate commitment
|
GO:0045165 |
210 |
0.242
|
|
|
|
protein localization to membrane
|
GO:0072657 |
108 |
0.242
|
|
|
|
urogenital system development
|
GO:0001655 |
261 |
0.239
|
|
|
|
canonical wnt signaling pathway involved in negative regulation of apoptotic process
|
GO:0044336 |
4 |
0.239
|
|
|
|
regulation of myeloid leukocyte differentiation
|
GO:0002761 |
58 |
0.239
|
|
|
|
microtubule based process
|
GO:0007017 |
236 |
0.237
|
|
|
|
intracellular protein transport
|
GO:0006886 |
204 |
0.236
|
|
|
|
homeostasis of number of cells
|
GO:0048872 |
210 |
0.235
|
|
|
|
regulation of melanocyte differentiation
|
GO:0045634 |
7 |
0.232
|
|
|
|
extrinsic apoptotic signaling pathway in absence of ligand
|
GO:0097192 |
55 |
0.231
|
|
|
|
positive regulation of gtpase activity
|
GO:0043547 |
85 |
0.230
|
|
|
|
gtp catabolic process
|
GO:0006184 |
143 |
0.227
|
|
|
|
cation transmembrane transport
|
GO:0098655 |
266 |
0.226
|
|
|
|
lymphocyte homeostasis
|
GO:0002260 |
64 |
0.226
|
|
|
|
apoptotic signaling pathway
|
GO:0097190 |
306 |
0.225
|
|
|
|
b cell activation
|
GO:0042113 |
161 |
0.225
|
|
|
|
regulation of purine nucleotide metabolic process
|
GO:1900542 |
169 |
0.224
|
|
|
|
cation homeostasis
|
GO:0055080 |
212 |
0.224
|
|
|
|
guanosine containing compound metabolic process
|
GO:1901068 |
144 |
0.218
|
|
|
|
t cell differentiation
|
GO:0030217 |
174 |
0.218
|
|
|
|
peptidyl serine phosphorylation
|
GO:0018105 |
74 |
0.217
|
|
|
|
regulation of b cell differentiation
|
GO:0045577 |
23 |
0.216
|
|
|
|
development of primary sexual characteristics
|
GO:0045137 |
143 |
0.216
|
|
|
|
regulation of lymphocyte differentiation
|
GO:0045619 |
107 |
0.215
|
|
|
|
axon ensheathment
|
GO:0008366 |
76 |
0.213
|
|
|
|
axonogenesis
|
GO:0007409 |
274 |
0.213
|
|
|
|
response to endoplasmic reticulum stress
|
GO:0034976 |
53 |
0.211
|
|
|
|
regulation of exocytosis
|
GO:0017157 |
61 |
0.203
|
|
|
|
ribonucleoside metabolic process
|
GO:0009119 |
245 |
0.203
|
|
|
|
protein maturation
|
GO:0051604 |
176 |
0.203
|
|
|
|
regulation of map kinase activity
|
GO:0043405 |
120 |
0.201
|
|
|
|
cellular response to organonitrogen compound
|
GO:0071417 |
145 |
0.199
|
|
|
|
purine nucleoside triphosphate catabolic process
|
GO:0009146 |
203 |
0.198
|
|
|
|
myeloid leukocyte differentiation
|
GO:0002573 |
119 |
0.197
|
|
|
|
myelination
|
GO:0042552 |
74 |
0.193
|
|
|
|
regulation of ion transmembrane transporter activity
|
GO:0032412 |
54 |
0.192
|
|
|
|
regulation of nucleoside metabolic process
|
GO:0009118 |
130 |
0.188
|
|
|
|
endosome organization
|
GO:0007032 |
9 |
0.182
|
|
|
|
peptidyl serine modification
|
GO:0018209 |
83 |
0.179
|
|
|
|
nucleoside phosphate catabolic process
|
GO:1901292 |
222 |
0.179
|
|
|
|
canonical wnt signaling pathway
|
GO:0060070 |
130 |
0.175
|
|
|
|
regulation of mast cell proliferation
|
GO:0070666 |
4 |
0.175
|
|
|
|
leukocyte activation involved in immune response
|
GO:0002366 |
126 |
0.172
|
|
|
|
cellular response to peptide hormone stimulus
|
GO:0071375 |
92 |
0.171
|
|
|
|
positive regulation of apoptotic process involved in mammary gland involution
|
GO:0060058 |
4 |
0.169
|
|
|
|
t cell activation
|
GO:0042110 |
289 |
0.169
|
|
|
|
alpha beta t cell activation
|
GO:0046631 |
91 |
0.168
|
|
|
|
regulation of hormone levels
|
GO:0010817 |
211 |
0.168
|
|
|
|
odontogenesis
|
GO:0042476 |
78 |
0.166
|
|
|
|
kit signaling pathway
|
GO:0038109 |
3 |
0.165
|
|
|
|
spermatid development
|
GO:0007286 |
108 |
0.165
|
|
|
|
nucleoside triphosphate catabolic process
|
GO:0009143 |
205 |
0.162
|
|
|
|
transmission of nerve impulse
|
GO:0019226 |
76 |
0.161
|
|
|
|
learning or memory
|
GO:0007611 |
148 |
0.160
|
|
|
|
regulation of cysteine type endopeptidase activity involved in apoptotic signaling pathway
|
GO:2001267 |
4 |
0.158
|
|
|
|
negative regulation of protein metabolic process
|
GO:0051248 |
282 |
0.158
|
|
|
|
cellular divalent inorganic cation homeostasis
|
GO:0072503 |
127 |
0.157
|
|
|
|
extrinsic apoptotic signaling pathway via death domain receptors
|
GO:0008625 |
34 |
0.156
|
|
|
|
positive regulation of t cell differentiation
|
GO:0045582 |
52 |
0.154
|
|
|
|
extrinsic apoptotic signaling pathway
|
GO:0097191 |
126 |
0.153
|
|
|
|
positive regulation of cell development
|
GO:0010720 |
237 |
0.152
|
|
|
|
lymphocyte mediated immunity
|
GO:0002449 |
139 |
0.152
|
|
|
|
ketone body metabolic process
|
GO:1902224 |
3 |
0.152
|
|
|
|
endomembrane system organization
|
GO:0010256 |
147 |
0.151
|
|
|
|
b cell homeostasis
|
GO:0001782 |
34 |
0.150
|
|
|
|
germ cell development
|
GO:0007281 |
185 |
0.150
|
|
|
|
regulation of t cell differentiation
|
GO:0045580 |
83 |
0.149
|
|
|
|
positive regulation of proteolysis
|
GO:0045862 |
85 |
0.148
|
|
|
|
response to granulocyte macrophage colony stimulating factor
|
GO:0097012 |
3 |
0.148
|
|
|
|
positive regulation of intracellular transport
|
GO:0032388 |
70 |
0.146
|
|
|
|
purine nucleoside metabolic process
|
GO:0042278 |
241 |
0.146
|
|
|
|
positive regulation of nucleoside metabolic process
|
GO:0045979 |
91 |
0.145
|
|
|
|
antigen processing and presentation of lipid antigen via mhc class ib
|
GO:0048003 |
3 |
0.143
|
|
|
|
cytotoxic t cell degranulation
|
GO:0043316 |
2 |
0.142
|
|
|
|
nucleobase containing small molecule metabolic process
|
GO:0055086 |
352 |
0.142
|
|
|
|
regulation of metal ion transport
|
GO:0010959 |
106 |
0.142
|
|
|
|
positive regulation of cysteine type endopeptidase activity
|
GO:2001056 |
39 |
0.142
|
|
|
|
short chain fatty acid metabolic process
|
GO:0046459 |
6 |
0.141
|
|
|
|
protein insertion into mitochondrial membrane involved in apoptotic signaling pathway
|
GO:0001844 |
4 |
0.139
|
|
|
|
embryonic placenta development
|
GO:0001892 |
98 |
0.139
|
|
|
|
regulation of homeostatic process
|
GO:0032844 |
182 |
0.138
|
|
|
|
skin development
|
GO:0043588 |
220 |
0.138
|
|
|
|
purine ribonucleoside catabolic process
|
GO:0046130 |
205 |
0.137
|
|
|
|
negative regulation of cellular amine metabolic process
|
GO:0033239 |
1 |
0.136
|
|
|
|
t cell activation involved in immune response
|
GO:0002286 |
43 |
0.136
|
|
|
|
positive regulation of endocytosis
|
GO:0045807 |
42 |
0.135
|
|
|
|
regulation of leukocyte apoptotic process
|
GO:2000106 |
56 |
0.132
|
|
|
|
regulation of protein kinase activity
|
GO:0045859 |
232 |
0.131
|
|
|
|
regulation of nucleotide metabolic process
|
GO:0006140 |
169 |
0.131
|
|
|
|
cell activation involved in immune response
|
GO:0002263 |
126 |
0.131
|
|
|
|
establishment of synaptic vesicle localization
|
GO:0097480 |
57 |
0.130
|
|
|
|
protein modification by small protein conjugation or removal
|
GO:0070647 |
207 |
0.127
|
|
|
|
cellular ketone metabolic process
|
GO:0042180 |
84 |
0.127
|
|
|
|
intrinsic apoptotic signaling pathway in response to dna damage
|
GO:0008630 |
57 |
0.125
|
|
|
|
liposaccharide metabolic process
|
GO:1903509 |
27 |
0.125
|
|
|
|
divalent inorganic cation transport
|
GO:0072511 |
178 |
0.124
|
|
|
|
wnt signaling pathway
|
GO:0016055 |
188 |
0.124
|
|
|
|
nitrogen compound transport
|
GO:0071705 |
271 |
0.124
|
|
|
|
programmed necrotic cell death
|
GO:0097300 |
28 |
0.124
|
|
|
|
mesenchyme development
|
GO:0060485 |
152 |
0.124
|
|
|
|
positive regulation of purine nucleotide metabolic process
|
GO:1900544 |
114 |
0.122
|
|
|
|
activation of immune response
|
GO:0002253 |
138 |
0.122
|
|
|
|
osteoclast differentiation
|
GO:0030316 |
62 |
0.120
|
|
|
|
myeloid leukocyte activation
|
GO:0002274 |
83 |
0.120
|
|
|
|
ribose phosphate metabolic process
|
GO:0019693 |
291 |
0.120
|
|
|
|
positive t cell selection
|
GO:0043368 |
23 |
0.119
|
|
|
|
exocytosis
|
GO:0006887 |
121 |
0.119
|
|
|
|
endoplasmic reticulum localization
|
GO:0051643 |
2 |
0.119
|
|
|
|
alpha beta t cell differentiation involved in immune response
|
GO:0002293 |
30 |
0.119
|
|
|
|
generation of precursor metabolites and energy
|
GO:0006091 |
103 |
0.117
|
|
|
|
cellular response to insulin stimulus
|
GO:0032869 |
78 |
0.117
|
|
|
|
response to heat
|
GO:0009408 |
27 |
0.116
|
|
|
|
calcium ion homeostasis
|
GO:0055074 |
127 |
0.116
|
|
|
|
negative regulation of intracellular signal transduction
|
GO:1902532 |
167 |
0.115
|
|
|
|
glycolipid metabolic process
|
GO:0006664 |
25 |
0.115
|
|
|
|
positive regulation of nucleotide catabolic process
|
GO:0030813 |
88 |
0.115
|
|
|
|
activation of cysteine type endopeptidase activity
|
GO:0097202 |
27 |
0.114
|
|
|
|
negative regulation of protein phosphorylation
|
GO:0001933 |
126 |
0.114
|
|
|
|
small gtpase mediated signal transduction
|
GO:0007264 |
97 |
0.113
|
|
|
|
muscle cell differentiation
|
GO:0042692 |
261 |
0.113
|
|
|
|
carbohydrate metabolic process
|
GO:0005975 |
230 |
0.112
|
|
|
|
regulation of phagocytosis
|
GO:0050764 |
33 |
0.112
|
|
|
|
response to radiation
|
GO:0009314 |
165 |
0.111
|
|
|
|
positive regulation of apoptotic process
|
GO:0043065 |
217 |
0.111
|
|
|
|
hematopoietic progenitor cell differentiation
|
GO:0002244 |
143 |
0.111
|
|
|
|
regulation of cellular response to oxidative stress
|
GO:1900407 |
19 |
0.110
|
|
|
|
multicellular organism growth
|
GO:0035264 |
161 |
0.109
|
|
|
|
positive regulation of cysteine type endopeptidase activity involved in apoptotic process
|
GO:0043280 |
36 |
0.109
|
|
|
|
macromolecule catabolic process
|
GO:0009057 |
281 |
0.108
|
|
|
|
response to oxidative stress
|
GO:0006979 |
123 |
0.108
|
|
|
|
cell type specific apoptotic process
|
GO:0097285 |
268 |
0.107
|
|
|
|
defense response to virus
|
GO:0051607 |
68 |
0.107
|
|
|
|
rhythmic process
|
GO:0048511 |
174 |
0.106
|
|
|
|
cellular response to radiation
|
GO:0071478 |
28 |
0.106
|
|
|
|
regulation of nucleotide catabolic process
|
GO:0030811 |
122 |
0.106
|
|
|
|
phagocytosis
|
GO:0006909 |
66 |
0.104
|
|
|
|
somatic cell dna recombination
|
GO:0016444 |
51 |
0.104
|
|
|
|
regulation of neuron apoptotic process
|
GO:0043523 |
122 |
0.104
|
|
|
|
positive regulation of mitochondrial membrane permeability
|
GO:0035794 |
12 |
0.103
|
|
|
|
cellular carbohydrate metabolic process
|
GO:0044262 |
119 |
0.103
|
|
|
|
protein processing
|
GO:0016485 |
163 |
0.102
|
|
|
|
natural killer cell mediated cytotoxicity
|
GO:0042267 |
29 |
0.100
|
Human |
|
|
regulation of rho protein signal transduction
|
GO:0035023 |
71 |
0.099
|
|
|
|
membrane lipid metabolic process
|
GO:0006643 |
53 |
0.098
|
|
|
|
positive regulation of cellular amine metabolic process
|
GO:0033240 |
5 |
0.097
|
|
|
|
positive regulation of protein modification process
|
GO:0031401 |
299 |
0.097
|
|
|
|
natural killer cell activation
|
GO:0030101 |
44 |
0.096
|
|
|
|
mast cell proliferation
|
GO:0070662 |
4 |
0.096
|
|
|
|
regulation of cellular ketone metabolic process
|
GO:0010565 |
66 |
0.096
|
|
|
|
cellular response to dna damage stimulus
|
GO:0006974 |
207 |
0.095
|
|
|
|
protein catabolic process
|
GO:0030163 |
221 |
0.095
|
|
|
|
mapk cascade
|
GO:0000165 |
281 |
0.095
|
|
|
|
stem cell differentiation
|
GO:0048863 |
268 |
0.094
|
|
|
|
actin filament based movement
|
GO:0030048 |
23 |
0.094
|
|
|
|
lipid storage
|
GO:0019915 |
36 |
0.094
|
|
|
|
interferon beta biosynthetic process
|
GO:0045350 |
4 |
0.094
|
|
|
|
protein targeting to vacuole
|
GO:0006623 |
3 |
0.093
|
|
|
|
regulation of cysteine type endopeptidase activity involved in apoptotic process
|
GO:0043281 |
62 |
0.093
|
|
|
|
organic acid biosynthetic process
|
GO:0016053 |
86 |
0.092
|
|
|
|
activation of cysteine type endopeptidase activity involved in apoptotic process by cytochrome c
|
GO:0008635 |
4 |
0.092
|
|
|
|
nuclear division
|
GO:0000280 |
158 |
0.091
|
|
|
|
positive regulation of leukocyte differentiation
|
GO:1902107 |
86 |
0.091
|
|
|
|
phospholipid metabolic process
|
GO:0006644 |
87 |
0.091
|
|
|
|
regulation of protein serine threonine kinase activity
|
GO:0071900 |
157 |
0.091
|
|
|
|
regulation of cysteine type endopeptidase activity
|
GO:2000116 |
65 |
0.090
|
|
|
|
female sex differentiation
|
GO:0046660 |
84 |
0.090
|
|
|
|
cellular protein catabolic process
|
GO:0044257 |
155 |
0.089
|
|
|
|
calcium ion transport
|
GO:0006816 |
159 |
0.089
|
|
|
|
regulation of gtp catabolic process
|
GO:0033124 |
113 |
0.089
|
|
|
|
divalent inorganic cation homeostasis
|
GO:0072507 |
138 |
0.089
|
|
|
|
epithelial tube morphogenesis
|
GO:0060562 |
303 |
0.089
|
|
|
|
activation of membrane attack complex
|
GO:0001905 |
4 |
0.087
|
|
|
|
stem cell development
|
GO:0048864 |
219 |
0.087
|
|
|
|
thymus development
|
GO:0048538 |
41 |
0.087
|
|
|
|
positive regulation of exocytosis
|
GO:0045921 |
20 |
0.086
|
|
|
|
carbohydrate derivative biosynthetic process
|
GO:1901137 |
183 |
0.086
|
|
|
|
positive regulation of melanocyte differentiation
|
GO:0045636 |
5 |
0.086
|
|
|
|
leukocyte apoptotic process
|
GO:0071887 |
71 |
0.086
|
|
|
|
regulation of rho gtpase activity
|
GO:0032319 |
58 |
0.086
|
|
|
|
negative regulation of lymphocyte apoptotic process
|
GO:0070229 |
24 |
0.084
|
|
|
|
ras protein signal transduction
|
GO:0007265 |
77 |
0.084
|
|
|
|
innate immune response
|
GO:0045087 |
157 |
0.084
|
Human |
|
|
negative regulation of homeostatic process
|
GO:0032845 |
71 |
0.084
|
|
|
|
male sex differentiation
|
GO:0046661 |
109 |
0.084
|
|
|
|
angiogenesis
|
GO:0001525 |
201 |
0.084
|
|
|
|
developmental maturation
|
GO:0021700 |
193 |
0.083
|
|
|
|
protein localization to organelle
|
GO:0033365 |
185 |
0.083
|
|
|
|
spermatid differentiation
|
GO:0048515 |
115 |
0.083
|
|
|
|
leukocyte mediated cytotoxicity
|
GO:0001909 |
62 |
0.082
|
Human |
|
|
establishment of protein localization to organelle
|
GO:0072594 |
118 |
0.082
|
|
|
|
sensory organ morphogenesis
|
GO:0090596 |
242 |
0.081
|
|
|
|
regulation of endopeptidase activity
|
GO:0052548 |
89 |
0.081
|
|
|
|
regulation of chemotaxis
|
GO:0050920 |
53 |
0.081
|
|
|
|
positive regulation of nucleotide metabolic process
|
GO:0045981 |
114 |
0.080
|
|
|
|
regulation of protein localization
|
GO:0032880 |
231 |
0.080
|
|
|
|
cell junction organization
|
GO:0034330 |
77 |
0.080
|
|
|
|
positive regulation of protein phosphorylation
|
GO:0001934 |
242 |
0.079
|
|
|
|
glycerolipid metabolic process
|
GO:0046486 |
122 |
0.079
|
|
|
|
regulation of neuron death
|
GO:1901214 |
134 |
0.079
|
|
|
|
cellular response to gamma radiation
|
GO:0071480 |
4 |
0.079
|
|
|
|
regulation of natural killer cell activation
|
GO:0032814 |
22 |
0.078
|
|
|
|
myeloid cell homeostasis
|
GO:0002262 |
114 |
0.078
|
|
|
|
mast cell apoptotic process
|
GO:0033024 |
5 |
0.077
|
|
|
|
renal system development
|
GO:0072001 |
225 |
0.077
|
|
|
|
positive regulation of mapk cascade
|
GO:0043410 |
170 |
0.077
|
|
|
|
tyrosine metabolic process
|
GO:0006570 |
4 |
0.077
|
|
|
|
intracellular mrna localization
|
GO:0008298 |
4 |
0.077
|
|
|
|
regulation of synaptic plasticity
|
GO:0048167 |
87 |
0.076
|
|
|
|
establishment of protein localization to vacuole
|
GO:0072666 |
4 |
0.076
|
|
|
|
negative regulation of phosphate metabolic process
|
GO:0045936 |
184 |
0.076
|
|
|
|
negative regulation of protein modification process
|
GO:0031400 |
163 |
0.075
|
|
|
|
single organismal cell cell adhesion
|
GO:0016337 |
131 |
0.075
|
|
|
|
negative regulation of anoikis
|
GO:2000811 |
2 |
0.074
|
|
|
|
wound healing
|
GO:0042060 |
157 |
0.074
|
|
|
|
positive regulation of map kinase activity
|
GO:0043406 |
84 |
0.074
|
|
|
|
tissue remodeling
|
GO:0048771 |
102 |
0.074
|
|
|
|
lipid biosynthetic process
|
GO:0008610 |
179 |
0.073
|
|
|
|
forebrain development
|
GO:0030900 |
302 |
0.072
|
|
|
|
regionalization
|
GO:0003002 |
337 |
0.072
|
|
|
|
negative regulation of lymphocyte activation
|
GO:0051250 |
91 |
0.072
|
|
|
|
regulation of myeloid cell apoptotic process
|
GO:0033032 |
19 |
0.071
|
|
|
|
neuron maturation
|
GO:0042551 |
29 |
0.071
|
|
|
|
leukocyte mediated immunity
|
GO:0002443 |
174 |
0.071
|
|
|
|
response to hydrogen peroxide
|
GO:0042542 |
32 |
0.070
|
|
|
|
single organism cell adhesion
|
GO:0098602 |
156 |
0.070
|
|
|
|
neuron projection extension
|
GO:1990138 |
64 |
0.070
|
|
|
|
regulation of cellular amino acid metabolic process
|
GO:0006521 |
5 |
0.070
|
|
|
|
regulation of peptidase activity
|
GO:0052547 |
96 |
0.069
|
|
|
|
development of primary female sexual characteristics
|
GO:0046545 |
73 |
0.069
|
|
|
|
negative regulation of cellular amino acid metabolic process
|
GO:0045763 |
0 |
0.068
|
|
|
|
gonad development
|
GO:0008406 |
141 |
0.068
|
|
|
|
natural killer cell mediated immunity
|
GO:0002228 |
29 |
0.068
|
Human |
|
|
regulation of kinase activity
|
GO:0043549 |
249 |
0.068
|
|
|
|
positive regulation of kinase activity
|
GO:0033674 |
155 |
0.067
|
|
|
|
positive regulation of smooth muscle cell migration
|
GO:0014911 |
4 |
0.067
|
|
|
|
protein localization to vacuole
|
GO:0072665 |
4 |
0.067
|
|
|
|
myeloid cell apoptotic process
|
GO:0033028 |
22 |
0.067
|
|
|
|
myeloid leukocyte migration
|
GO:0097529 |
57 |
0.067
|
|
|
|
positive regulation of regulated secretory pathway
|
GO:1903307 |
10 |
0.067
|
|
|
|
phosphatidylinositol metabolic process
|
GO:0046488 |
45 |
0.066
|
|
|
|
multicellular organismal homeostasis
|
GO:0048871 |
164 |
0.066
|
|
|
|
positive regulation of activation of membrane attack complex
|
GO:0001970 |
2 |
0.066
|
|
|
|
kidney development
|
GO:0001822 |
213 |
0.066
|
|
|
|
transmembrane receptor protein tyrosine kinase signaling pathway
|
GO:0007169 |
247 |
0.066
|
|
|
|
ear development
|
GO:0043583 |
200 |
0.066
|
|
|
|
cell chemotaxis
|
GO:0060326 |
81 |
0.065
|
|
|
|
negative regulation of cell development
|
GO:0010721 |
169 |
0.065
|
|
|
|
positive regulation of neuroepithelial cell differentiation
|
GO:1902913 |
5 |
0.065
|
|
|
|
fatty acid biosynthetic process
|
GO:0006633 |
41 |
0.065
|
|
|
|
regulation of nitrogen utilization
|
GO:0006808 |
2 |
0.065
|
|
|
|
regulation of transmembrane transport
|
GO:0034762 |
128 |
0.065
|
|
|
|
response to light stimulus
|
GO:0009416 |
135 |
0.064
|
|
|
|
anatomical structure homeostasis
|
GO:0060249 |
145 |
0.064
|
|
|
|
sensory perception
|
GO:0007600 |
245 |
0.063
|
|
|
|
cell adhesion
|
GO:0007155 |
329 |
0.063
|
|
|
|
g protein coupled receptor signaling pathway
|
GO:0007186 |
243 |
0.063
|
|
|
|
response to starvation
|
GO:0042594 |
65 |
0.063
|
|
|
|
carboxylic acid biosynthetic process
|
GO:0046394 |
86 |
0.062
|
|
|
|
cell substrate adhesion
|
GO:0031589 |
130 |
0.062
|
|
|
|
regulation of peptidyl tyrosine phosphorylation
|
GO:0050730 |
93 |
0.062
|
|
|
|
retina development in camera type eye
|
GO:0060041 |
119 |
0.062
|
|
|
|
developmental cell growth
|
GO:0048588 |
84 |
0.061
|
|
|
|
regulation of receptor activity
|
GO:0010469 |
41 |
0.061
|
|
|
|
apoptotic process involved in mammary gland involution
|
GO:0060057 |
4 |
0.061
|
|
|
|
erk1 and erk2 cascade
|
GO:0070371 |
77 |
0.061
|
|
|
|
body morphogenesis
|
GO:0010171 |
45 |
0.061
|
|
|
|
positive regulation of transferase activity
|
GO:0051347 |
167 |
0.061
|
|
|
|
positive regulation of protein serine threonine kinase activity
|
GO:0071902 |
106 |
0.061
|
|
|
|
regulation of transforming growth factor beta receptor signaling pathway
|
GO:0017015 |
43 |
0.061
|
|
|
|
regulation of oxidative stress induced neuron intrinsic apoptotic signaling pathway
|
GO:1903376 |
3 |
0.061
|
|
|
|
negative regulation of myeloid cell apoptotic process
|
GO:0033033 |
11 |
0.061
|
|
|
|
genetic imprinting
|
GO:0071514 |
27 |
0.060
|
|
|
|
mitochondrion organization
|
GO:0007005 |
134 |
0.060
|
|
|
|
adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains
|
GO:0002460 |
145 |
0.060
|
|
|
|
immune response regulating signaling pathway
|
GO:0002764 |
125 |
0.060
|
|
|
|
response to ethanol
|
GO:0045471 |
18 |
0.060
|
|
|
|
regulation of myeloid cell differentiation
|
GO:0045637 |
96 |
0.060
|
|
|
|
visual perception
|
GO:0007601 |
52 |
0.059
|
|
|
|
negative regulation of phosphorylation
|
GO:0042326 |
166 |
0.059
|
|
|
|
cellular response to growth factor stimulus
|
GO:0071363 |
197 |
0.058
|
|
|
|
positive regulation of release of cytochrome c from mitochondria
|
GO:0090200 |
5 |
0.058
|
|
|
|
cellular response to oxidative stress
|
GO:0034599 |
76 |
0.058
|
|
|
|
cell division
|
GO:0051301 |
120 |
0.058
|
|
|
|
regulation of mitochondrion organization
|
GO:0010821 |
27 |
0.058
|
|
|
|
regulation of osteoclast differentiation
|
GO:0045670 |
36 |
0.056
|
|
|
|
regulation of epithelial cell proliferation
|
GO:0050678 |
141 |
0.056
|
|
|
|
zymogen activation
|
GO:0031638 |
41 |
0.056
|
|
|
|
positive regulation of endopeptidase activity
|
GO:0010950 |
43 |
0.056
|
|
|
|
positive regulation of protein complex assembly
|
GO:0031334 |
45 |
0.056
|
|
|
|
regulation of purine nucleotide catabolic process
|
GO:0033121 |
122 |
0.056
|
|
|
|
chemotaxis
|
GO:0006935 |
247 |
0.055
|
|
|
|
eye pigmentation
|
GO:0048069 |
3 |
0.055
|
|
|
|
t cell homeostasis
|
GO:0043029 |
35 |
0.055
|
|
|
|
positive regulation of natural killer cell activation
|
GO:0032816 |
15 |
0.055
|
|
|
|
response to organic cyclic compound
|
GO:0014070 |
198 |
0.055
|
|
|
|
transforming growth factor beta receptor signaling pathway
|
GO:0007179 |
71 |
0.055
|
|
|
|
posttranscriptional regulation of gene expression
|
GO:0010608 |
155 |
0.055
|
|
|
|
ectopic germ cell programmed cell death
|
GO:0035234 |
9 |
0.055
|
|
|
|
response to insulin
|
GO:0032868 |
100 |
0.055
|
|
|
|
membrane fusion
|
GO:0061025 |
38 |
0.054
|
|
|
|
skeletal system development
|
GO:0001501 |
356 |
0.054
|
|
|
|
mesenchymal cell differentiation
|
GO:0048762 |
107 |
0.054
|
|
|
|
muscle system process
|
GO:0003012 |
141 |
0.054
|
|
|
|
positive regulation of cell killing
|
GO:0031343 |
33 |
0.054
|
|
|
|
glycerophospholipid metabolic process
|
GO:0006650 |
71 |
0.053
|
|
|
|
t cell selection
|
GO:0045058 |
34 |
0.053
|
|
|
|
post embryonic organ development
|
GO:0048569 |
17 |
0.053
|
|
|
|
regulation of ph
|
GO:0006885 |
26 |
0.053
|
|
|
|
cellular component assembly involved in morphogenesis
|
GO:0010927 |
139 |
0.053
|
|
|
|
negative regulation of cellular component organization
|
GO:0051129 |
194 |
0.053
|
|
|
|
positive regulation of cellular protein catabolic process
|
GO:1903364 |
34 |
0.053
|
|
|
|
thymocyte apoptotic process
|
GO:0070242 |
19 |
0.052
|
|
|
|
positive regulation of cell motility
|
GO:2000147 |
116 |
0.052
|
|
|
|
cell matrix adhesion
|
GO:0007160 |
68 |
0.052
|
|